Detalhe da pesquisa
1.
Understanding Policy Decisions and Their Implications Regarding Preventive Interventions for Respiratory Syncytial Virus (RSV) Infection in Canadian Infants: A Primer for Nurses.
Neonatal Netw
; 42(5): 291-302, 2023 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37657806
2.
Respiratory Syncytial Virus Immunoprophylaxis with Palivizumab: 12-Year Observational Study of Usage and Outcomes in Canada.
Am J Perinatol
; 39(15): 1668-1677, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33657636
3.
Hospitalization for Respiratory Syncytial Virus in Children with Down Syndrome Less than 2 Years of Age: A Systematic Review and Meta-Analysis.
J Pediatr
; 203: 92-100.e3, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30266507
4.
Respiratory syncytial virus hospitalization and incurred morbidities the season after prophylaxis.
Paediatr Child Health
; 23(7): 441-446, 2018 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-30374219
5.
Impact of using the International Risk Scoring Tool on the cost-utility of palivizumab for preventing severe respiratory syncytial virus infection in Canadian moderate-to-late preterm infants.
J Med Econ
; 26(1): 630-643, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37067826
6.
A new cost-utility analysis assessing risk factor-guided prophylaxis with palivizumab for the prevention of severe respiratory syncytial virus infection in Italian infants born at 29-35 weeks' gestational age.
PLoS One
; 18(8): e0289828, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37561741
7.
Molecular evolution of respiratory syncytial virus fusion gene, Canada, 2006-2010.
Emerg Infect Dis
; 18(1): 120-4, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22264682
8.
Use of thrombolytic agents to treat neonatal thrombosis in clinical practice.
Blood Coagul Fibrinolysis
; 33(4): 193-200, 2022 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35285449
9.
The impact of prophylaxis on paediatric intensive care unit admissions for RSV infection: a retrospective, single-centre study.
Eur J Pediatr
; 170(7): 907-13, 2011 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-21174120
10.
Respiratory Syncytial Virus Prophylaxis in Immunocompromised Children: Outcomes From the Canadian RSV Evaluation Study of Palivizumab Registry Over Twelve Seasons (2005-2017).
Pediatr Infect Dis J
; 39(6): 539-545, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32235248
11.
Comparison of the cost of hospitalization for respiratory syncytial virus disease versus palivizumab prophylaxis in Canadian Inuit infants.
Pediatr Infect Dis J
; 28(8): 702-6, 2009 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-19461555
12.
Respiratory Syncytial Virus Prophylaxis in Neurologic and Muscular Disorders in the Canadian Respiratory Syncytial Virus Evaluation Study of Palivizumab.
Pediatr Infect Dis J
; 38(8): 775-780, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30985509
13.
Prioritising respiratory syncytial virus prevention in low-income and middle-income countries.
Lancet Glob Health
; 11(5): e655-e657, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37061306
14.
The association of platelets with failed patent ductus arteriosus closure after a primary course of indomethacin or ibuprofen: a systematic review and meta-analysis.
J Matern Fetal Neonatal Med
; 30(2): 127-133, 2017 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26955892
15.
Comparing First- and Second-year Palivizumab Prophylaxis in Patients With Hemodynamically Significant Congenital Heart Disease in the CARESS Database (2005-2015).
Pediatr Infect Dis J
; 36(5): 445-450, 2017 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-28403044
16.
Global respiratory syncytial virus-associated mortality in young children (RSV GOLD): a retrospective case series.
Lancet Glob Health
; 5(10): e984-e991, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28911764
17.
How to use unfractionated heparin to treat neonatal thrombosis in clinical practice.
Blood Coagul Fibrinolysis
; 27(6): 605-14, 2016 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26656898
18.
Patent foramen ovale and stroke in childhood: A systematic review of the literature.
Eur J Paediatr Neurol
; 20(4): 500-11, 2016 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-27169856
19.
Rebuttal: palivizumab for the prevention of respiratory syncytial virus infection.
Can Fam Physician
; 56(10): 988-91, 2010 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-20944037
20.
Palivizumab prophylaxis for respiratory syncytial virus in Canada: utilization and outcomes.
Pediatr Infect Dis J
; 21(6): 512-8, 2002 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-12182374